Craig Coleman
Professor/Pharmacy Practice
Storrs Mansfield
Are you Craig Coleman?
How to update your information.
Scholarly Contributions
620 Scholarly Contributions
“Effectiveness and safety of rivaroxaban versus warfarin in nonvalvular atrial fibrillation patients with coronary or peripheral artery disease”. Event: ESC Congress 2019, Paris.
2019
Research Type: Poster/Presentation
“Case clinic sessions: Tackling the challenge: High-risk NVAF patients”
2019
Research Type: Poster/Presentation
What Proportion of Hospitalizations in Acute Medically Ill Patients Qualify for Extended Thromboprophylaxis with Oral Anticoagulation?
2019
Research Type: Poster/Presentation
Safety and Effectiveness of Factor Xa Inhibitors Versus Warfarin in Nonvalvular Atrial Fibrillation Patients at High-Risk for Falls
2019
Research Type: Poster/Presentation
“Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis”. Event: ASH 2019, Orlando.
2019
Research Type: Poster/Presentation
“Effectiveness and Safety of Rivaroxaban and Warfarin for Prevention of Major Adverse Cardiovascular or Limb Events in Nonvalvular Atrial Fibrillation Patients with Type 2 Diabetes”. Event: ISTH 2019, Melbourne.
2019
Research Type: Poster/Presentation
“Rivaroxaban Versus Warfarin and Renal Outcomes in Non-valvular Atrial Fibrillation Patients with Diabetes”. Event: ISTH 2019, Melbourne.
2019
Research Type: Poster/Presentation
Communication of Medication Nonmedical Switching Policies and Procedures by Insurance Companies: Results of an E-Survey.
2020
Research Type: Journal Article
Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation.
2020
Research Type: Journal Article
Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors.
2020
Research Type: Journal Article
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes.
2020
Research Type: Journal Article
Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review.
2020
Research Type: Journal Article
Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis.
2020
Research Type: Journal Article
Comparative Effectiveness of Analgesics to Reduce Acute Pain in the Prehospital Setting.
2020
Research Type: Journal Article
Physicians' perspectives regarding non-medical switching of prescription medications: Results of an internet e-survey.
2020
Research Type: Journal Article
Burden-of-Illness Associated with Bleeding-Related Hospitalizations in Atrial Fibrillation Patients: Findings from the Nationwide Readmission Database.
2020
Research Type: Journal Article
Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis.
2020
Research Type: Journal Article
Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism.
2020
Research Type: Journal Article
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis.
2020
Research Type: Journal Article